PATRICIA A. GABOW, M.D.; THOMAS J. HANSON, M.D.; MORDECAI M. POPOVTZER, M.D.; ROBERT W. SCHRIER, M.D.
Six hypoparathyroid patients were treated with oral furosemide for 4 days. All six had a significant decrease in serum ionized calcium level from the control period (4.05 ± 0.31 mg/dl) to the furosemide period (3.46 ± 0.26 mg/dl, P < 0.005). In five patients, the decrease in serum ionized calcium concentration occurred in association with an increase in urinary calcium excretion. Although serum immunoreactive parathyroid hormone level increased in five patients, it was insufficient to return serum ionized calcium to control levels. Changes in serum phosphorus, magnesium, or pH could not account for the observed decrease in serum ionized calcium concentration. It is necessary to monitor serum ionized calcium level in hypoparathyroid patients during furosemide therapy.
Learn more about subscription options.
Register Now for a free account.
GABOW PA, HANSON TJ, POPOVTZER MM, SCHRIER RW. Furosemide-Induced Reduction in Ionized Calcium in Hypoparathyroid Patients. Ann Intern Med. 1977;86:579–581. doi: 10.7326/0003-4819-86-5-579
Download citation file:
Published: Ann Intern Med. 1977;86(5):579-581.
Endocrine and Metabolism, Parathyroid Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only